Back to Agenda
New Collaboration Models with Regulators and Patients
Session Chair(s)
Brian Mayhew, MA, MBA
Executive Director, Regulatory Policy, Novartis Pharmaceuticals Corporation, United States
This session will explore how the utilisation of advances in technology (such as big data, wearables, cloud computing) will open new opportunities & challenges for collaboration between companies with regulators, payers and patients: Is the present interaction model appropriate; should authorities be involved earlier in data collection & analysis, and how will this change patient engagement?
Speaker(s)
Scott Askin, MSC
Global Program Regulatory Director, Novartis Pharma AG, Switzerland
Alison Cave
Chief Safety Officer, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Regulator Perspective on the Use of New Technology for Evidence Generation on Regulatory Decision Making
Trishna Bharadia
Patient Advocate, International Speaker, Writer, Advisor and Content Reviewer, The Spark Global, United Kingdom
Patient Perspective
Have an account?